CARMCarisma Therapeutics - Common StockCARM info
$1.00info0.00%24h
Global rank26420
Market cap$40.36M
Change 7d0.00%
YTD Performance-65.75%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Carisma Therapeutics - Common Stock (CARM) Stock Overview

    Carisma Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases. The company's clinical and pre-clinical programs include CT-0508 and CT-0525 targeting HER2 overexpressing tumors; and CT-1119, a CAR-Monocyte for mesothelin overexpressing solid tumors. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

    CARM Stock Information

    Symbol
    CARM
    Address
    3675 Market StreetPhiladelphia, PA 19104United States
    Founded
    -
    Trading hours
    -
    Website
    https://carismatx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    267-491-6422

    Carisma Therapeutics - Common Stock (CARM) Price Chart

    -
    Value:-

    Carisma Therapeutics - Common Stock Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.00
    N/A
    Market Cap
    $40.36M
    N/A
    Shares Outstanding
    40.36M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org